Coverage
-
March 18, 2015
The Federal Trade Commission on Tuesday criticized Reckitt Benckiser Pharmaceuticals Inc.'s proposed special masters to oversee the review of which Suboxone materials the drugmaker has to turn over to the antitrust watchdog, saying it preferred a Christian & Barton LLP partner for the role.
3 other articles on this case.
View all »